APP and Alzheimer disease: Using the APP/PS1 mouse model of AD, it was found that RIN3 mRNA and protein levels are increased in the hippocampus and cortex from only 3 months of age, which greatly precedes the formation of Aβ plaques in this model—which usually occurs at ~6–7 months [131].